Published in Cancer Weekly, September 5th, 2006
For the 6 months ended June 30, 2006, the company reported revenue of $1,391.2 million, EBITDA of $128 million and net income of $16.2 million.
The results of US Oncology Holdings include those of US Oncology, its wholly owned subsidiary, through which all operations are conducted. The results of operations and the financial position of Holdings are substantially identical to those of US Oncology,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.